Promega Corporation

Specific Detection of Biologically Active MAP Kinase using Anti-ACTIVE™ MAPK pAb

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Promega's Anti-ACTIVE™ MAPK pAb, directed against the dually-phosphorylated form of the MAP kinase enzymes, allows for sensitive and specific detection of the active form of ERK1 and ERK2. This highly purified antibody is provided at high titer and can be used in a variety of immunodetection applications.

Promega Notes 58, 34.

Erik Schaefer and Rich Moravec

Promega Corporation
Publication Date: 1996

Download Article (193 KB)

Prefer a different language?

Your country is set to Spain. Your language is set to español. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.